Kehamilan dengan Covid-19

Isi Artikel Utama

Rijanto i Agoeng Basoek

Abstrak

Abstract :

Pregnant women are considered to have a high risk of morbidity and even higher mortality due to their susceptibility to viral respiratory pathogens and special immunologic conditions, during the course of pregnancy. Several studies assessed that Covid-19 infection during pregnancy was reported to cause harm. With patient manifestations with severe conditions, including spontaneous abortion, imminent preterm labor, fetal distress, preterm delivery, neonatal asphyxia, neonatal pneumonia, intra uterine fetal death (IUFD), and neonatal death.

Keywords: Pregnancy, Complication, And Covid-19

Rincian Artikel

Referensi

  1. Daftar Pustaka
  2. RCM|Royal college of Midwives and the RCOG|Royal college of Obstetricians & Gynecologists. (2020). Coronavirus ( COVID-19 ) Infection in Pregnancy:Information for healthcare professionals Version 11: Published Friday 24 July 2020. July, 1–68. https://www.rcog.org.uk/globalassets/documents/guidelines/2021-02-19-coronavirus-covid-19-infection-in-pregnancy-v13.pdf
  3. Hayakawa S, Komineâ€Aizawa S, Mor GG. Covidâ€19 pandemic and pregnancy. Journal of Obstetrics and Gynaecology Research. 2020 Oct;46(10):1958-66.https://doi.org/10.1111/jog.14384
  4. Ji L, Zhan Y, Hua F, Li F, Zou S, Wang W, Song D, Min Z, Chen H, Cheng Y. The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia. PloS one. 2012 Dec 3;7(12):e50909. https://doi.org/10.1371/journal.pone.0050909
  5. H. Check J, Szekeresâ€Bartho J, O'Shaughnessy A. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation. American Journal of Reproductive Immunology. 1996 Mar;35(3):277-80. https://doi.org/10.1111/j.1600-0897.1996.tb00045.x
  6. Szekeresâ€Bartho J, Faust ZS, Varga P, Szereday L, Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. American Journal of Reproductive Immunology. 1996 Apr;35(4):348-51. https://doi.org/10.1111/j.1600-0897.1996.tb00492.x
  7. Muyayalo KP, Huang DH, Zhao SJ, Xie T, Mor G, Liao AH. COVIDâ€19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes. American Journal of Reproductive Immunology. 2020 Nov;84(5):e13304. https://doi.org/10.1111/aji.13304
  8. Prochaska E, Jang M, Burd I. COVIDâ€19 in pregnancy: Placental and neonatal involvement. American Journal of Reproductive Immunology. 2020 Nov;84(5):e13306. https://doi.org/10.1111/aji.13306
  9. Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, Benachi A, De Luca D. Transplacental transmission of SARS-CoV-2 infection. Nature communications. 2020 Jul 14;11(1):1-7. https://doi.org/10.1038/s41467-020-17436-6
  10. Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during pregnancy and possible vertical transmission. American journal of perinatology. 2020 Jun;37(08):861-5. https://doi.org/10.1055/s-0040-1710050
  11. D'Souza R, Ashraf R, Rowe H, Zipursky J, Clarfield L, Maxwell C, Arzola C, Lapinsky S, Paquette K, Murthy S, Cheng MP. Pregnancy and COVIDâ€19: pharmacologic considerations. Ultrasound in Obstetrics & Gynecology. 2021 Feb;57(2):195-203. https://doi.org/10.1002/uog.23116